Cargando…
Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease
A 73-year-old man with liver cirrhosis and advanced chronic kidney disease was admitted to our hospital due to bilateral lower leg edema and appetite loss. Furosemide to treat fluid retention markedly decreased extracellular water compared with intracellular water, but the addition of tolvaptan equa...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599930/ https://www.ncbi.nlm.nih.gov/pubmed/30713322 http://dx.doi.org/10.2169/internalmedicine.2174-18 |
_version_ | 1783431016146272256 |
---|---|
author | Nagayama, Izumi Masuda, Takahiro Nakagawa, Saki Murakami, Takuya Ohara, Ken Matsuoka, Ryo Kobayashi, Takahisa Maeshima, Akito Akimoto, Tetsu Saito, Osamu Muto, Shigeaki Nagata, Daisuke |
author_facet | Nagayama, Izumi Masuda, Takahiro Nakagawa, Saki Murakami, Takuya Ohara, Ken Matsuoka, Ryo Kobayashi, Takahisa Maeshima, Akito Akimoto, Tetsu Saito, Osamu Muto, Shigeaki Nagata, Daisuke |
author_sort | Nagayama, Izumi |
collection | PubMed |
description | A 73-year-old man with liver cirrhosis and advanced chronic kidney disease was admitted to our hospital due to bilateral lower leg edema and appetite loss. Furosemide to treat fluid retention markedly decreased extracellular water compared with intracellular water, but the addition of tolvaptan equally decreased both with a greater diuretic response than furosemide alone. Furthermore, tolvaptan administration increased the plasma colloid osmotic pressure, which might facilitate the shift of fluid from the extravascular space to the intravascular space. This is the first case showing different effects on the fluid distribution between furosemide and additional tolvaptan in the same patient. |
format | Online Article Text |
id | pubmed-6599930 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-65999302019-07-01 Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease Nagayama, Izumi Masuda, Takahiro Nakagawa, Saki Murakami, Takuya Ohara, Ken Matsuoka, Ryo Kobayashi, Takahisa Maeshima, Akito Akimoto, Tetsu Saito, Osamu Muto, Shigeaki Nagata, Daisuke Intern Med Case Report A 73-year-old man with liver cirrhosis and advanced chronic kidney disease was admitted to our hospital due to bilateral lower leg edema and appetite loss. Furosemide to treat fluid retention markedly decreased extracellular water compared with intracellular water, but the addition of tolvaptan equally decreased both with a greater diuretic response than furosemide alone. Furthermore, tolvaptan administration increased the plasma colloid osmotic pressure, which might facilitate the shift of fluid from the extravascular space to the intravascular space. This is the first case showing different effects on the fluid distribution between furosemide and additional tolvaptan in the same patient. The Japanese Society of Internal Medicine 2019-02-01 2019-06-01 /pmc/articles/PMC6599930/ /pubmed/30713322 http://dx.doi.org/10.2169/internalmedicine.2174-18 Text en Copyright © 2019 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Nagayama, Izumi Masuda, Takahiro Nakagawa, Saki Murakami, Takuya Ohara, Ken Matsuoka, Ryo Kobayashi, Takahisa Maeshima, Akito Akimoto, Tetsu Saito, Osamu Muto, Shigeaki Nagata, Daisuke Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease |
title | Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease |
title_full | Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease |
title_fullStr | Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease |
title_full_unstemmed | Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease |
title_short | Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease |
title_sort | different effects on fluid distribution between tolvaptan and furosemide in a liver cirrhosis patient with chronic kidney disease |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599930/ https://www.ncbi.nlm.nih.gov/pubmed/30713322 http://dx.doi.org/10.2169/internalmedicine.2174-18 |
work_keys_str_mv | AT nagayamaizumi differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease AT masudatakahiro differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease AT nakagawasaki differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease AT murakamitakuya differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease AT oharaken differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease AT matsuokaryo differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease AT kobayashitakahisa differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease AT maeshimaakito differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease AT akimototetsu differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease AT saitoosamu differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease AT mutoshigeaki differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease AT nagatadaisuke differenteffectsonfluiddistributionbetweentolvaptanandfurosemideinalivercirrhosispatientwithchronickidneydisease |